Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
D647788-5mg
|
5mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$110.90
|
|
|
D647788-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$180.90
|
|
|
D647788-25mg
|
25mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$380.90
|
|
Amino acids
| Synonyms | N3-Oxalyl-L-2,3-diaminopropanoate | A13552 | 3-N-Oxalyl-L-2,3-diaminopropanoic acid | Dencichin | UNII-O8VT5BZ48B | beta-ODAP | N-Oxalyl-L-alpha-beta-diaminopropionic acid (BOAA,ODAP) | oxalyldiaminopropionic acid, (L-Ala)-isomer | beta-N-Oxalyl-L-alpha,b |
|---|---|
| Biochemical and Physiological Mechanisms | Dencichin is a non-protein amino acid originally extracted from Panax notoginseng , and can inhibit HIF-prolyl hydroxylase-2 (PHD-2) activity. |
| Storage Temp | Protected from light,Store at -80°C |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Product Description |
Dencichin is a non-protein amino acid originally extracted from Panax notoginseng , and can inhibit HIF-prolyl hydroxylase-2 (PHD-2) activity. In Vitro Dencichin (β-ODAP, 10 μM, 50 μM, 100 μM and 200 μM) increases HRE expression by 1.3±0.09, 2.5±0.07, 4.2±0.15 and 1.3±0.07 fold respectively compared to control. Dencichin has intermolecular interactions with PHD-2. Dencichin (10 μM, 100 μM, 1 mM) significantly inhibits cell proliferation and extracellular matrix (ECM) proteins accumulation of HBZY-1 cells, and reduces the secretion of collagen I (Col I), collagen IV (Col IV), and fibronectin (FN). MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo Dencichin improves metabolism disorder in diabetic nephropathy (DN) secondary to type II diabetes mellitus (DM) model. Dencichin (80, 160 mg/kg/day, p.o.) significantly prevents the up-regulation of TCH, TG, LDL, and HbAlc and the down-regulation of HDL in DN rats induced by STZ injection. Dencichin also attenuates renal injury induced in the DN secondary to type II DM model. Dencichin alleviates pancreas damage in the STZ-induced DN model. Dencichin regulates protein expression in the TGF-β/Smad signalling pathway in STZ-induced DN models. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Assay Cells are cultured in 6-well plates with glucose (LG) or high glucose control (HG) and then treated with valsartan (1.0 × 10 -3 M) or Dencichin (1.0 × 10 -5 M, 1.0 × 10 -4 M and 1.0 × 10 -3 M) for 24 h before analysing the activation of FN, Col I, and Col IV expression by ELISA and analysing MMP-9 and TIMP-1 expression by immunofluorescence. Each experiment is repeated at least three times throughout the study. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal administration Male SD rats weighted approximately 200 ± 20 g (eight weeks old) are kept at 23 ± 2°C. The rats are randomLy allotted into two groups: normal group (n = 16) and diabetic nephropathy (DN) group (n = 60). The normal rats fed with normal diet and vehicle fall into the normal control group (NC, n = 8) and the normal rats fed with normal diet and Dencichin fall into the Dencichin control group (De C, n = 8). The rats in the diabetic group are fed the high-sugar-high-fat diet (composition: Common breeding material 54.6%, lard oil 16.9%, sucrose 14%, casein 10.2%, gunk 2.1%, maltodextrin 2.2%). Five weeks later, DN is induced by administering of 40 mg/kg STZ though intraperitoneal injection, and the normal rats are treated with vehiclecitrate buffer (0.1 M, pH 4.2). Next, the DN rats (n = 32) are assigned into four groups and oral administered with metformin hydrochloride (a positive control) at 80 mg/kg/day, (DN+Met, n = 8), which is dissolve into distilled water to make a 2 mg/mL solution before use; vehicle control for the DN control group (DN, n = 8), or Dencichin. The Dencichin group is divided into a high Dencichin group ( 160 mg/kg/day ; DN+De H, n = 8) and a low Dencichin group ( 80 mg/kg/day ; DN+De L, n = 8), which are dissolved into distilled water to make a 5 mg/mL and 2.5 mg/mL solution before use and oral administered at the dosage once per day. Blood glucose is measured each month. 8 w after administering with Dencichin, the rats are killed . aladdin has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:PHD-2 |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Subclass | Amino acids, peptides, and analogues |
| Intermediate Tree Nodes | Amino acids and derivatives - Alpha amino acids and derivatives - Alpha amino acids |
| Direct Parent | L-alpha-amino acids |
| Alternative Parents | Dicarboxylic acids and derivatives Secondary carboxylic acid amides Amino acids Carboxylic acids Organopnictogen compounds Organic oxides Monoalkylamines Hydrocarbon derivatives Carbonyl compounds |
| Molecular Framework | Aliphatic acyclic compounds |
| Substituents | L-alpha-amino acid - Dicarboxylic acid or derivatives - Carboxamide group - Secondary carboxylic acid amide - Amino acid - Carboxylic acid - Organic oxide - Organopnictogen compound - Primary amine - Organooxygen compound - Organonitrogen compound - Primary aliphatic amine - Organic oxygen compound - Organic nitrogen compound - Carbonyl group - Amine - Hydrocarbon derivative - Aliphatic acyclic compound |
| Description | This compound belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
| External Descriptors | N(beta)-acyl-L-2,3-diaminopropionic acid |
|
|
|
| IUPAC Name | (2S)-2-amino-3-(oxaloamino)propanoic acid |
|---|---|
| INCHI | InChI=1S/C5H8N2O5/c6-2(4(9)10)1-7-3(8)5(11)12/h2H,1,6H2,(H,7,8)(H,9,10)(H,11,12)/t2-/m0/s1 |
| InChIKey | NEEQFPMRODQIKX-REOHCLBHSA-N |
| Smiles | C(C(C(=O)O)N)NC(=O)C(=O)O |
| Isomeric SMILES | C([C@@H](C(=O)O)N)NC(=O)C(=O)O |
| Alternate CAS | 5302-45-4 |
| PubChem CID | 440259 |
| MeSH Entry Terms | (2-amino-2-carboxymethyl)-L-oxamic acid;2-oxalylamino-3-aminopropionic acid;3-amino-N-(carboxycarbonyl)-DL-alanine;3-amino-N-(carboxycarbonyl)alanine;3-oxalylamino-2-aminopropionic acid;beta-N-oxalylamino-L-alanine;beta-N-oxalylaminoalanine;beta-N-oxalyla |
| Molecular Weight | 176.13 |
| Solubility | DMSO : 5 mg/mL (28.39 mM; Need ultrasonic) H2O : 5 mg/mL (28.39 mM; Need ultrasonic) |
|---|---|
| Molecular Weight | 176.130 g/mol |
| XLogP3 | -4.100 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 176.043 Da |
| Monoisotopic Mass | 176.043 Da |
| Topological Polar Surface Area | 130.000 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 214.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
| 1. Jing Chen, Ying Yuan, Xiaoku Ran, Na Guo, Deqiang Dou. (2018) Metabolomics analysis based on a UPLC-Q-TOF-MS metabolomics approach to compare Lin-Xia-Shan-Shen and garden ginseng. RSC Advances, 8 (53): (30616-30623). |